Drug class
Nasal Decongestants
Nasal decongestants are a therapeutic drug class composed primarily of sympathomimetic agents, available in both topical intranasal and systemic oral formulations. Read more about Nasal Decongestants
168 drugs in this class 44 manufacturers
Drugs in Nasal Decongestants
NOSE DROPS (phenylephrine HCl)
NOSE DROPS (phenylephrine HCl)
DECONGESTANT INHALER (L-desoxyephedrine)
VAPOR INHALER (levmetamfetamine)
ORIGINAL NASAL SPRAY (oxymetazoline HCl)
ORIGINAL NASAL SPRAY (oxymetazoline HCl)
VICKS SINEX (oxymetazoline HCl)
NASAL SPRAY (oxymetazoline HCl)
Nasal decongestants are a therapeutic drug class composed primarily of sympathomimetic agents, available in both topical intranasal and systemic oral formulations.
These medications function predominantly through alpha-adrenergic receptor agonism, inducing vasoconstriction of engorged mucosal blood vessels, which reduces respiratory tract mucosal edema and improves nasal airway patency.
They are indicated for the temporary symptomatic relief of nasal congestion associated with upper respiratory tract infections, allergic rhinitis, and sinusitis.
Common agents in this class include topical oxymetazoline and systemic pseudoephedrine.
-
fda.gov
Nasal decongestants are a therapeutic drug class composed primarily of sympathomimetic agents, available in both topical intranasal and systemic oral formulations Common agents in this class include topical oxymetazoline and systemic pseudoephedrine
-
medlineplus.gov
Nasal decongestants are a therapeutic drug class composed primarily of sympathomimetic agents, available in both topical intranasal and systemic oral formulations These medications function predominantly through alpha-adrenergic receptor agonism, inducing vasoconstriction of engorged mucosal blood vessels, which reduces respiratory tract mucosal edema and improves nasal airway patency Common agents in this class include topical oxymetazoline and systemic pseudoephedrine
-
medlineplus.gov
Nasal decongestants are a therapeutic drug class composed primarily of sympathomimetic agents, available in both topical intranasal and systemic oral formulations These medications function predominantly through alpha-adrenergic receptor agonism, inducing vasoconstriction of engorged mucosal blood vessels, which reduces respiratory tract mucosal edema and improves nasal airway patency Common agents in this class include topical oxymetazoline and systemic pseudoephedrine
-
medlineplus.gov
These medications function predominantly through alpha-adrenergic receptor agonism, inducing vasoconstriction of engorged mucosal blood vessels, which reduces respiratory tract mucosal edema and improves nasal airway patency
-
medlineplus.gov
These medications function predominantly through alpha-adrenergic receptor agonism, inducing vasoconstriction of engorged mucosal blood vessels, which reduces respiratory tract mucosal edema and improves nasal airway patency
-
fda.gov
They are indicated for the temporary symptomatic relief of nasal congestion associated with upper respiratory tract infections, allergic rhinitis, and sinusitis
-
fda.gov
They are indicated for the temporary symptomatic relief of nasal congestion associated with upper respiratory tract infections, allergic rhinitis, and sinusitis
-
clevelandclinic.org
They are indicated for the temporary symptomatic relief of nasal congestion associated with upper respiratory tract infections, allergic rhinitis, and sinusitis
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.